March 26, 2020
Dear Advocate,
Please join an upcoming webinar on pandemic vaccine development, scheduled for Thursday, April 2, 10am EDT.
In the second installment of AVAC’s webinar series on COVID-19 and its relationship to HIV,
Dr. Mark Feinberg, CEO of
IAVI, will share experiences and lessons from Ebola and HIV vaccine development that might be applied to COVID-19 vaccine development. Dr. Feinberg will also describe the history and role of the Coalition for Epidemic Preparedness Innovations (
CEPI), which supports vaccine development against emerging infectious diseases, including COVID-19.
REGISTER HERE.
The first webinar in the series featured a range of voices on COVID-19 and HIV.
Dr. Carl Dieffenbach, Director of the Division of AIDS (DAIDS) at the US NIH answered questions about risk for people living with HIV, the impact of COVID-19 on HIV research, and the status of research into treatments and vaccines for COVID-19.
Lillian Mworeko of ICW-EA and
Yvette Raphael of APHA framed issues that must be incorporated into a robust advocacy agenda for sub-Saharan Africa, a region bracing for a tide of COVID-19 cases already seen in Asia, Europe and North America. The advocates also shared their
Call to African leaders to accelerate action on COVID-19.
Additional Resources
- AVAC maintains a Resources for Advocates sheet that provides links to the latest COVID-19 information on prevention and transmission, the research pipeline, and a growing list of country-specific resources.
While there is anxiety and uncertainty right now, we take great comfort in our relationships, knowing we have each other for support, solace and motivation. Thank you, as ever, for your partnership and commitment to our important work together.
Best,
AVAC
